FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100673222> ?p ?o ?g. }

• W2100673222 endingPage "e001317" @default.
• W2100673222 startingPage "e001317" @default.
• W2100673222 abstract "<h3>Objectives</h3> Lipid abnormalities associated with antiretroviral therapy in people with HIV infection are more frequent with protease inhibitors (PI)-based regimens. Whether effects extend to patients receiving a PI subsequent to failure on non-nucleoside reverse-transcriptase inhibitors (NNRTI)-based regimen is still unknown. We investigated the effects of secondary treatment with a PI on the lipid profile in a group of patients with HIV infection in Cameroon. <h3>Design</h3> This was a cross-sectional study. <h3>Setting</h3> This study was carried out at the registered centre for HIV treatment of the Yaounde Jamot Hospital in Cameroon. <h3>Participants</h3> Participants were consecutively recruited between November 2009 and January 2010. There were 138 HIV-1 patients on initial treatment with an NNRTI regimen and 66 HIV patients on secondary treatment with a PI for at least 12 months. Lipid abnormalities were based on the National Cholesterol Education Program, Adult Treatment Panel III criteria. <h3>Outcome measures</h3> Levels of lipid parameters among patients on PI and NNRTI. <h3>Results</h3> Median (IQR) levels (mg/dl), NNRTI-treated versus PI-treated patients were 185 (149–225) and 189 (147–244) for total cholesterol, 46 (27–66) and 42 (28–82) for high-density lipoprotein (HDL)-cholesterol, 121 (90–169) and 126.9 (71–176) for low-density lipoprotein (LDL)-cholesterol, 134 (98–174) and 138 (111–167) for triglycerides, and 4.3 (2.9–6.2) and 5.1 (2.6–7.9) for total/HDL-cholesterol ratio (all p>0.32). The most frequent lipid abnormality in the two groups was high LDL-cholesterol (46.4% (NNRTI) vs 54.5% (PI)). The occurrence of lipid abnormalities was similar in the two groups (all p>0.29). <h3>Conclusions</h3> The use of PI does not appear to deteriorate the lipid profile of HIV patients above and beyond abnormalities induced by an unsuccessful initial treatment with NNRTI. Monitoring of lipid profile during HIV treatment regardless of the regimens would improve timely detection and management of abnormalities, to mitigate related risks." @default.
• W2100673222 created "2016-06-24" @default.
• W2100673222 creator A5000055109 @default.
• W2100673222 creator A5005888309 @default.
• W2100673222 creator A5016936793 @default.
• W2100673222 creator A5043836054 @default.
• W2100673222 creator A5058575023 @default.
• W2100673222 date "2012-01-01" @default.
• W2100673222 modified "2023-10-05" @default.
• W2100673222 title "Dyslipidaemia in HIV-1-infected patients receiving protease inhibitors after initial treatment with first-line-based non-nucleoside reverse transcriptase inhibitors: a cross-sectional study" @default.
• W2100673222 cites W188808338 @default.
• W2100673222 cites W1984717040 @default.
• W2100673222 cites W1987131358 @default.
• W2100673222 cites W1994469981 @default.
• W2100673222 cites W2004476675 @default.
• W2100673222 cites W2007618996 @default.
• W2100673222 cites W2031198260 @default.
• W2100673222 cites W2073671744 @default.
• W2100673222 cites W2073738273 @default.
• W2100673222 cites W2074511171 @default.
• W2100673222 cites W2088423598 @default.
• W2100673222 cites W2106343349 @default.
• W2100673222 cites W2112572728 @default.
• W2100673222 cites W2116512634 @default.
• W2100673222 cites W2119843180 @default.
• W2100673222 cites W2130068732 @default.
• W2100673222 cites W2135594909 @default.
• W2100673222 cites W2139508877 @default.
• W2100673222 cites W2157138119 @default.
• W2100673222 cites W2159176140 @default.
• W2100673222 cites W2163400856 @default.
• W2100673222 cites W2318289184 @default.
• W2100673222 cites W2425577674 @default.
• W2100673222 cites W2477872031 @default.
• W2100673222 cites W75946149 @default.
• W2100673222 cites W2337109902 @default.
• W2100673222 doi "https://doi.org/10.1136/bmjopen-2012-001317" @default.
• W2100673222 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3425906" @default.
• W2100673222 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22874631" @default.
• W2100673222 hasPublicationYear "2012" @default.
• W2100673222 type Work @default.
• W2100673222 sameAs 2100673222 @default.
• W2100673222 citedByCount "4" @default.
• W2100673222 countsByYear W21006732222016 @default.
• W2100673222 countsByYear W21006732222019 @default.
• W2100673222 countsByYear W21006732222020 @default.
• W2100673222 crossrefType "journal-article" @default.
• W2100673222 hasAuthorship W2100673222A5000055109 @default.
• W2100673222 hasAuthorship W2100673222A5005888309 @default.
• W2100673222 hasAuthorship W2100673222A5016936793 @default.
• W2100673222 hasAuthorship W2100673222A5043836054 @default.
• W2100673222 hasAuthorship W2100673222A5058575023 @default.
• W2100673222 hasBestOaLocation W21006732221 @default.
• W2100673222 hasConcept C126322002 @default.
• W2100673222 hasConcept C142052008 @default.
• W2100673222 hasConcept C142462285 @default.
• W2100673222 hasConcept C142724271 @default.
• W2100673222 hasConcept C181199279 @default.
• W2100673222 hasConcept C185592680 @default.
• W2100673222 hasConcept C203014093 @default.
• W2100673222 hasConcept C2776543447 @default.
• W2100673222 hasConcept C2776714187 @default.
• W2100673222 hasConcept C2777351918 @default.
• W2100673222 hasConcept C2778163477 @default.
• W2100673222 hasConcept C2781143361 @default.
• W2100673222 hasConcept C2781413609 @default.
• W2100673222 hasConcept C2993143319 @default.
• W2100673222 hasConcept C3013748606 @default.
• W2100673222 hasConcept C55493867 @default.
• W2100673222 hasConcept C71240020 @default.
• W2100673222 hasConcept C71924100 @default.
• W2100673222 hasConcept C90924648 @default.
• W2100673222 hasConceptScore W2100673222C126322002 @default.
• W2100673222 hasConceptScore W2100673222C142052008 @default.
• W2100673222 hasConceptScore W2100673222C142462285 @default.
• W2100673222 hasConceptScore W2100673222C142724271 @default.
• W2100673222 hasConceptScore W2100673222C181199279 @default.
• W2100673222 hasConceptScore W2100673222C185592680 @default.
• W2100673222 hasConceptScore W2100673222C203014093 @default.
• W2100673222 hasConceptScore W2100673222C2776543447 @default.
• W2100673222 hasConceptScore W2100673222C2776714187 @default.
• W2100673222 hasConceptScore W2100673222C2777351918 @default.
• W2100673222 hasConceptScore W2100673222C2778163477 @default.
• W2100673222 hasConceptScore W2100673222C2781143361 @default.
• W2100673222 hasConceptScore W2100673222C2781413609 @default.
• W2100673222 hasConceptScore W2100673222C2993143319 @default.
• W2100673222 hasConceptScore W2100673222C3013748606 @default.
• W2100673222 hasConceptScore W2100673222C55493867 @default.
• W2100673222 hasConceptScore W2100673222C71240020 @default.
• W2100673222 hasConceptScore W2100673222C71924100 @default.
• W2100673222 hasConceptScore W2100673222C90924648 @default.
• W2100673222 hasIssue "4" @default.
• W2100673222 hasLocation W21006732221 @default.
• W2100673222 hasLocation W21006732222 @default.
• W2100673222 hasLocation W21006732223 @default.
• W2100673222 hasLocation W21006732224 @default.
• W2100673222 hasOpenAccess W2100673222 @default.
• W2100673222 hasPrimaryLocation W21006732221 @default.

• next